MIBEFRADIL

MIBEFRADIL Struktur
116666-63-8
CAS-Nr.
116666-63-8
Englisch Name:
MIBEFRADIL
Synonyma:
CS-1455;MIBEFRADIL;(1s-cis)-orid;ro40-5967/001;Mibefradil HCl;Mibefradil 2HCl;Mibefradil diHCl;Ro 40-5967 hydrate;MIBEFRADIL USP/EP/BP;Mibefradil(Ro 40-5967)
CBNumber:
CB6503891
Summenformel:
C29H40Cl2FN3O3
Molgewicht:
568.5506032
MOL-Datei:
116666-63-8.mol

MIBEFRADIL Eigenschaften

Schmelzpunkt:
128℃
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
Löslichkeit
H2O: 24 mg/mL, soluble
pka
4.8; 5.5(at 25℃)
Aggregatzustand
solid
Farbe
white
Stabilität:
Hygroscopic
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
WGK Germany  3
RTECS-Nr. AI8977250
Toxizität LD50 in mice, rats (mg/kg): 35, 23 i.v.; >800, >800 orally (Clozel)
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H302 Gesundheitsschädlich bei Verschlucken. Akute Toxizität oral Kategorie 4 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P270, P301+P312, P330, P501
Sicherheit
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P305+P351+P338 BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.

MIBEFRADIL Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Posicor was launched in Argentina, Azerbaijan, Brazil, the Chile, Czech Republic, Denmark, Germany, Ireland, Kazakhstan, the Netherlands, Norway, Peru, the Philippines, Switzerland, Thailand, Turkmenistan, the UK, the US and Venezuela for use in hypertension. It can be assembled in five steps from 4-(1-benzyloxy-Nmethylformamido) butyric acid with o-phenylenediamine and isobutylchloroformate. Posicor binds to calcium channels in a manner that overlaps the Verapamil, SR-33557 and Diltiazem binding site without effecting the dihydropyridine binding site. Thus it blocks a wide variety of calcium channels with selectivity for T-type followed sequentially by L-type. There is also some calcium agonist activity along with sodium and potassium channel activity. It is chemically distinct from the other calcium antagonists (first member of a new catagory of tetralol calcium antagonists). It has the ability to lower heart rate with no negative inotropic effects and is as effective as Amlodipine and more effective than Diltiazem for the treatment of mild to moderate hypertension. Serious drug interactions are possible because Posicor inhibits both CYP2D6 and CYP3A4.

Verwenden

Mibefradil has been used as a T-type calcium channel blocker in various cells. It has also been used to reduce apoptosis of retinal ganglion cells (RGC) in EphB2-Fc.

MIBEFRADIL Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


MIBEFRADIL Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 74)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19553 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Shaanxi Dideu Medichem Co. Ltd
+86-029-89586680 +86-18192503167
1026@dideu.com China 9030 58
Baoji Guokang Bio-Technology Co., Ltd.
0917-3909592 13892490616
gksales1@gk-bio.com China 9322 58
Sinoway Industrial co., ltd.
0592-5800732; +8613806035118
xie@china-sinoway.com China 990 58
Alfa Chemistry

Info@alfa-chemistry.com United States 24072 58
InvivoChem
+1-708-310-1919 +1-13798911105
sales@invivochem.cn United States 6393 58
Wuhan Topule Biopharmaceutical Co., Ltd
+8618327326525
masar@topule.com China 8474 58
LEAPCHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 43348 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 57511 58

116666-63-8()Verwandte Suche:


  • [(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methyl-amino]ethyl]-6-fluoro-1-isopropyl-tetralin-2-yl] 2-methoxyacetate dihydrochloride
  • MIBEFRADIL
  • Mibefradil diHCl
  • (1S,2S)-2-[2[[3-(2-Benzimidazolyl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride hydrate
  • (1s-cis)-orid
  • 2-(2-((3-(1h-benzimidazol-2-yl)propyl)methylamino)ethyl)-aceticaci
  • 6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenylester,dihydrochl
  • ro40-5967/001
  • Mibefradil hydrate dihydrochloride
  • Ro 40-5967 hydrate, (1S,2S)-2-[2[[3-(2-Benzimidazolylpropyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate hydrate dihydrochloride
  • Acetic acid, methoxy-, 2-(2-((3-(1H-benzimidazol-2-yl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, dihydrochloride, (1S-cis)-
  • Mibefradil HCl
  • Mibefradil dihydrochloride hydrate
  • Ro 40-5967 hydrate
  • Mibefradil(Ro 40-5967)
  • Mibefradil (hydrochloride)
  • Mibefradil 2HCl
  • Ro 40-5967 (dihydrochloride)
  • MIBEFRADIL USP/EP/BP
  • CS-1455
  • Mibefradil 2Hcl(Ro 40-5967)
  • Mibefradil dihydrochloride,inhibit,Calcium Channel,Mibefradil,Ro 40-5967,Inhibitor,Ca channels,Ca2+ channels
  • 116666-63-8
  • C29H38FN3O32HCl
  • C29H40Cl2FN3O3
Copyright 2019 © ChemicalBook. All rights reserved